Two Decades of THERANOSTICS in Neuroendocrine Tumors - Past, Presence and Future of Peptide Receptor Radionuclide Therapy (PRRT)

Richard Baum

doi:10.1530/endoabs.47.OC7

Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

OC7

Prev Next

Section Contents Cite

Endocrine Abstracts (2016) 47 OC7 | DOI: 10.1530/endoabs.47.OC7

Theranostics2016 4th Theranostics World Congress 2016 Spotlight on Neuroendocrine tumours (17 abstracts)

Two Decades of THERANOSTICS in Neuroendocrine Tumors – Past, Presence and Future of Peptide Receptor Radionuclide Therapy (PRRT)

Richard Baum

Err

Author affiliations

Zentralklinik Bad Berka, Bad Berka, Thuringia, Germany.

Abstract unavailable at the time of publishing

Volume 47

4th Theranostics World Congress

Theranostics World Congress

Browse other volumes

Summary Abstract Book Volume Editors Abstracts

Article tools

| Disclaimer

My recent searches

No recent searches.

My recently viewed abstracts

Two Decades of THERANOSTICS in Neuroendocrine Tumors - Past, Presence and Future of Peptide Receptor Radionuclide Therapy (PRRT) (<1 min ago)

Authors

Endocrine Abstracts Google Scholar Pub Med

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more